The premise and promise of low-intensity focused ultrasound for neuropsychiatric disorders

Low-intensity focused ultrasound (LIFU) is a noninvasive neuromodulation technique that uses acoustic energy to modulate neural activity. LIFU reaches both cortical and deep brain structures with millimeter precision, making it a candidate treatment approach for various neuropsychiatric conditions. The neuromodulatory effects of LIFU depend on the acoustic parameters of the protocol in conjunction with the underlying neurobiology of the target, though the mechanisms underlying these effects are still being characterized. Early clinical work spans depression, anxiety, substance use disorder, epilepsy, Parkinson's disease, and Alzheimer's disease, with trials that remain small and heterogeneous in target and protocol. Here we review the state of the field, covering how LIFU is delivered, the mechanisms proposed to underlie its effects, the evidence for target engagement in humans, and the clinical literature to date. In addition to investigating LIFU’s clinical efficacy, considerable foundational work remains before LIFU can be effectively deployed as a therapy. Overall, LIFU has considerable potential, but rigorous mechanistic and clinical research will be essential to define its therapeutic role.

Authors

Publication Details

Journal
PsyArXiv (OSF Preprints)
Published
2026-11-14
DOI
https://doi.org/10.31234/osf.io/6ujnt
Primary Topic
Ultrasound and Hyperthermia Applications
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

The premise and promise of low-intensity focused ultrasound for neuropsychiatric disorders

Brooke R. Staveland, Khaled Moussawi, Sierra D Brandts, Emme Brooke Chen
PsyArXiv (OSF Preprints)
Ultrasound and Hyperthermia Applications
preprint

The premise and promise of low-intensity focused ultrasound for neuropsychiatric disorders

Brooke R. Staveland, Khaled Moussawi, Sierra D Brandts, Emme Brooke Chen
preprint en

Abstract

Low-intensity focused ultrasound (LIFU) is a noninvasive neuromodulation technique that uses acoustic energy to modulate neural activity. LIFU reaches both cortical and deep brain structures with millimeter precision, making it a candidate treatment approach for various neuropsychiatric conditions. The neuromodulatory effects of LIFU depend on the acoustic parameters of the protocol in conjunction with the underlying neurobiology of the target, though the mechanisms underlying these effects are still being characterized. Early clinical work spans depression, anxiety, substance use disorder, epilepsy, Parkinson's disease, and Alzheimer's disease, with trials that remain small and heterogeneous in target and protocol. Here we review the state of the field, covering how LIFU is delivered, the mechanisms proposed to underlie its effects, the evidence for target engagement in humans, and the clinical literature to date. In addition to investigating LIFU’s clinical efficacy, considerable foundational work remains before LIFU can be effectively deployed as a therapy. Overall, LIFU has considerable potential, but rigorous mechanistic and clinical research will be essential to define its therapeutic role.

PsyArXiv (OSF Preprints)
Ultrasound and Hyperthermia Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon